Establishment Labs (NASDAQ:ESTA) Reaches New 1-Year High After Analyst Upgrade

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares reached a new 52-week high on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $71.00 to $80.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Establishment Labs traded as high as $74.35 and last traded at $74.15, with a volume of 792700 shares traded. The stock had previously closed at $72.03.

A number of other equities analysts have also weighed in on the company. Citigroup increased their price target on Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a report on Monday. Needham & Company LLC lifted their target price on shares of Establishment Labs from $70.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. BTIG Research upped their price target on shares of Establishment Labs from $70.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, November 14th. Finally, Wall Street Zen raised shares of Establishment Labs from a “sell” rating to a “hold” rating in a research note on Sunday, October 19th. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $78.14.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quarry LP purchased a new stake in Establishment Labs in the 3rd quarter worth approximately $34,000. State of Wyoming acquired a new position in shares of Establishment Labs in the third quarter worth $71,000. Osaic Holdings Inc. raised its holdings in shares of Establishment Labs by 900.0% during the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after acquiring an additional 1,800 shares in the last quarter. CWM LLC boosted its position in Establishment Labs by 45.9% during the second quarter. CWM LLC now owns 2,182 shares of the company’s stock valued at $93,000 after purchasing an additional 686 shares during the last quarter. Finally, PharVision Advisers LLC acquired a new stake in Establishment Labs during the third quarter valued at $203,000. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Stock Down 6.9%

The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10. The business has a 50 day simple moving average of $61.00 and a 200 day simple moving average of $47.45. The stock has a market cap of $2.02 billion, a PE ratio of -24.50 and a beta of 1.01.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.54) by $0.16. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The business had revenue of $53.78 million during the quarter, compared to analyst estimates of $52.28 million. During the same period in the previous year, the company earned ($0.59) EPS. The firm’s revenue was up 33.8% on a year-over-year basis. On average, equities research analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.